|
XRCC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.760000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.983450E-01 |
| Normal-vs-Stage2 |
1.718790E-01 |
| Normal-vs-Stage3 |
2.581600E-02 |
| Normal-vs-Stage4 |
4.971200E-01 |
| Stage1-vs-Stage2 |
5.224600E-01 |
| Stage1-vs-Stage3 |
1.400820E-01 |
| Stage1-vs-Stage4 |
9.556800E-01 |
| Stage2-vs-Stage3 |
6.973200E-01 |
| Stage2-vs-Stage4 |
6.483800E-01 |
| Stage3-vs-Stage4 |
3.920000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.774100E-02 |
| Normal-vs-AfricanAmerican |
8.082200E-01 |
| Normal-vs-Asian |
5.793000E-01 |
| Caucasian-vs-AfricanAmerican |
4.966800E-01 |
| Caucasian-vs-Asian |
4.978100E-02 |
| AfricanAmerican-vs-Asian |
5.488600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.352200E-01 |
| Normal-vs-Female |
2.724500E-02 |
| Male-vs-Female |
7.889700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.799200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.180400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.092820E-01 |
| Normal-vs-Age(81-100Yrs) |
6.711900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.324400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.212200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.740200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.310000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.282200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.329800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.06360000029504E-07 |
| Classical-VS-Follicular |
4.935800E-01 |
| Classical-VS-Other |
8.257600E-01 |
| Classical-VS-Normal |
3.255000E-01 |
| Tall-VS-Follicular |
9.156000E-04 |
| Tall-VS-Other |
1.456010E-01 |
| Tall-VS-Normal |
3.98840000026546E-07 |
| Follicular-VS-Other |
9.723400E-01 |
| Follicular-VS-Normal |
1.962410E-01 |
| Other-VS-Normal |
5.099400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.466220E-01 |
| Normal-vs-N1 |
6.632800E-01 |
| N0-vs-N1 |
5.597000E-01 |
|
|
